Skip NavigationSkip to Content

Possession of HLA Class II DRB1*1303 Associates with Reduced Viral Loads in Chronic HIV-1 Clade C and B Infection

  1. Author:
    Julg, B.
    Moodley, E. S.
    Qi, Y.
    Ramduth, D.
    Reddy, S.
    Mncube, Z.
    Gao, X. J.
    Goulder, P. J.
    Detels, R.
    Ndung'u, T.
    Walker, B. D.
    Carrington, M.
  2. Author Address

    [Qi, Ying; Gao, Xiaojiang; Carrington, Mary] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21702 USA. [Julg, Boris; Moodley, Eshia S.; Ramduth, Danni; Reddy, Shabashini; Mncube, Zenele; Goulder, Philip J.; Ndung'u, Thumbi; Walker, Bruce D.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa. [Julg, Boris; Moodley, Eshia S.; Ramduth, Danni; Reddy, Shabashini; Mncube, Zenele; Goulder, Philip J.; Ndung'u, Thumbi; Walker, Bruce D.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa. [Julg, Boris; Goulder, Philip J.; Ndung'u, Thumbi; Walker, Bruce D.; Carrington, Mary] Ragon Inst MGH MIT & Harvard, Boston, MA USA. [Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA. [Detels, Roger] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA. [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA. [Goulder, Philip J.] Univ Oxford, Dept Pediat, Oxford, England.;Carrington, M, NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Bldg 560,Room 21-89,Miller Dr, Frederick, MD 21702 USA.;carringm@mail.nih.gov
    1. Year: 2011
    2. Date: Mar
  1. Journal: Journal of Infectious Diseases
    1. 203
    2. 6
    3. Pages: 803-809
  2. Type of Article: Article
  3. ISSN: 0022-1899
  1. Abstract:

    Methods.In this study we investigated the effect of HLA class II alleles on HIV disease outcome and HIV-specific T cell responses in a cohort of 426 antiretroviral therapy-naive, HIV-1 clade C-infected, predominantly female black South Africans. Results.The HLA class II allele DRB1*1303 was independently associated with lower plasma viral loads in this population (P = .02), an association that was confirmed in a second cohort of 1436 untreated, HIV-1 clade B-infected, male European Americans, suggesting that DRB1*1303-mediated protection is independent of ethnicity, sex, and viral clade. Interestingly, DRB1*1303 carriage was not associated with an increased frequency of interferon (IFN) gamma-positive HIV-specific CD4(+) T cell responses. Conclusions.These data demonstrate the independent effect of an HLA class II allele, DRB1*1303, on HIV disease progression, in the absence of increased IFN-gamma-positive HIV-specific CD4(+) T cell frequencies, suggesting that the protective activity of DRB1*1303 may be mediated via an alternative mechanism.

    See More

External Sources

  1. DOI: 10.1093/infdis/jiq122
  2. WOS: 000287742700009

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel